Page 1 of 1

Opexa reverse split

Posted: Tue Jan 01, 2013 12:21 am
by NHE
As I had predicted almost a year ago, on December 14th Opexa executed another reverse split. This time it was 1:4. Since then, their stock has fallen an additional 35.2% in value. This does not seem to put them in a good position for their ongoing trial of Tovaxin (Tcelna) with SPMS.

http://www.opexatherapeutics.com/121412 ... cle=121412

NHE